Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 2, 1996, Pages 194-198

  Jarvis, G E ^a   Evans, R J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endotoxin; Horses; Platelet aggregation; Platelet activating factor; Platelets; Thromboxane A2

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; APAFANT; CARPROFEN; ENDOTOXIN; FLUNIXIN MEGLUMINE; MEPACRINE; NONSTEROID ANTIINFLAMMATORY AGENT; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; HORSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0029898985     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199603000-00021     Document Type: Conference Paper

References (15)

1. Muir III WW. Analgesics in the treatment of colic. In: Robinson NW, ed. Current Therapy in Equine Medicine - 2. Philadelphia: WB Saunders, 1987: 27-29.
2. Lees P, McKellar Q, May SA, Ludwig B. Pharmacodynamics and pharmacokinetics of carprofen in the horse. Equine Vet J 1994; 26: 203-208.
3. Olanoff LS, Cook JA, Eller T, et al. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. J Cardiovasc Pharmacol 1985; 51: 462-465.
4. Semrad SD, Hardee GE, Hardee MM, Moore JN. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Vet J 1987; 19: 201-206.
5. Foster AP, Cunningham FM, Lees P. Inflammatory effects of platelet activating factor (PAF) in equine skin. Equine Vet J 1992; 24: 208-214.
6. Terashita Z-I, Imura Y, Nishikawa K, Sumida S. Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur J Pharmacol 1985; 109: 257-261.
7. Heath MF, Evans RJ, Poole AW, et al. The effects of aspirin and paracetamol on the aggregation of equine blood platelets. J Vet Pharmacol Ther 1994; 17: 374-378.
8. Jarvis GE, Evans RJ. Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. Res Vet Sci 1994; 57: 317-324.
9. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol (Lond) 1963; 168: 178-195.
10. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behaviour in blood. J Pharmacol Methods 1980; 3: 135-158.
11. Jarvis GE. Endotoxaemia: the in vitro activation of equine platelets by endotoxin. PhD thesis, University of Cambridge, 1996.
12. Bates DM, Watts DG. Nonlinear Regression Analysis and its Applications. New York: John Wiley, 1988.
13. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978; 235: E97-E102.
14. 2 activity in human neutrophils. Stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst. J Immunol 1993; 151: 4918-4925.
15. Jancinová V, Nosál R, Petríková M. Platelet inactivation by cationic amphiphilic drugs. Eur J Clin Invest 1995; 25 (suppl 2): abstract 223.